课题基金 / 基金详情

项目摘要

项目成果

Ali I. Fattom的其他基金

相似基金

相关文献

中文摘要
翻译
NIAID/DAIT佐剂开发计划通过免疫学特性研究和主导化合物优化,直至并包括IND使能研究,支持开发新的候选疫苗佐剂,所有这些都是为了获得人类使用的许可。将使用目前获得许可的或新的研究疫苗对佐剂进行研究,以防止受到NIAID新出现和再次出现的传染病病原体的感染。
英文摘要
The NIAID/DAIT Adjuvant Development Program supports the development of new candidate vaccine adjuvants through immunological characterization studies and lead compound optimization, up to and including IND-enabling studies, all towards licensure for human use. Adjuvants will be studied with currently licensed or new investigational vaccines to protect against infection by NIAID emerging and re-emerging infectious disease pathogens.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DEVELOPMENT OF NANOVAX TM (OIL IN WATER NANOEMULSION ADJUVANT) FORMULATED ALLERGENS AS INTRANASAL IMMUNOTHERAPEUTIC VACCINES FOR PEANUT ALLERGY.
  • 批准号:
    10884987
  • 项目类别:
  • 资助金额:
    $7.93万
  • 财政年份:
    2020
  • 负责人:
    Ali I. Fattom
  • 依托单位:
DEVELOPMENT OF NANOVAX TM (OIL IN WATER NANOEMULSION ADJUVANT) FORMULATED ALLERGENS AS INTRANASAL IMMUNOTHERAPEUTIC VACCINES FOR PEANUT ALLERGY.
  • 批准号:
    10018153
  • 项目类别:
  • 资助金额:
    $29.99万
  • 财政年份:
    2019
  • 负责人:
    Ali I. Fattom
  • 依托单位:
DEVELOPMENT OF NANOVAX TM (OIL IN WATER NANOEMULSION ADJUVANT) FORMULATED ALLERGENS AS INTRANASAL IMMUNOTHERAPEUTIC VACCINES FOR PEANUT ALLERGY.
  • 批准号:
    10250294
  • 项目类别:
  • 资助金额:
    $291.65万
  • 财政年份:
    2019
  • 负责人:
    Ali I. Fattom
  • 依托单位:
Pre-Clinical Development of a Intranasal Bivalent gD2/gB2 HSV-2 Mucosal Vaccine
  • 批准号:
    10076038
  • 项目类别:
  • 资助金额:
    $99.87万
  • 财政年份:
    2017
  • 负责人:
    Ali I. Fattom
  • 依托单位:
海外基金